As of 2025-07-06, the Fair Value of Pulmonx Corp (LUNG) is -7.09 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.78 USD, the upside of Pulmonx Corp is -355.06%.
With the market price of 2.78 USD and our fair value calculation, Pulmonx Corp (LUNG) is not a good investment. Investing in LUNG stocks now will result in a potential loss of 355.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -32.23 | -48.66 | -58.92 | -60.84 | -56.39 | -51.41 |
| YoY growth | -55.70% | -50.98% | -21.09% | -3.26% | 7.31% | -24.74% |
| Market Cap (mil) | 111.92 |
| P/E | |
| Forward P/E |
| EPS | -1.42 |
| Avg earnings growth rate | -24.74% |
| TTM earnings | -57.09 |